Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines

(2010) K Cuschieri et al.   BRITISH JOURNAL OF CANCER

The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: An observational retrospective analysis of invasive cervical cancers

(2009) Ned Powell et al.   INTERNATIONAL JOURNAL OF CANCER

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom

(2009) Yoon Hong Choi et al.   VACCINE

Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study

(2008) S Hibbitts et al.   BRITISH JOURNAL OF CANCER